PHILADELPHIA (August 16, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Dapo Amosu, MS, PharmD, DPLA, as its new Senior Director of Pharmacy.
“Excellence in pharmacy, particularly in the highly specialized area of hematology/oncology, is critical to providing excellent clinical care. Dr. Amosu will serve as the second-ever head of pharmacy in Fox Chase’s history, leading a truly world-class operation to further shepherd our growth in this vital service area,” said Robert Uzzo, MD, MBA, FACS, President and CEO of Fox Chase.
Amosu will have responsibility for the medication use process for both the inpatient and ambulatory care environments, including purchasing/inventory and administrative pharmacy activities. He will work closely and collaboratively with clinicians, senior leadership, and colleagues from various departments regarding pharmacy programs and related patient care services, including the delivery of pharmaceutical services, the state of relevant technology and equipment, and patient safety matters.
He will also provide leadership, as needed, for the infusion center at Temple University Hospital – Main Campus and Temple Health – Chestnut Hill Hospital in collaboration with the health system’s Chief Pharmacy Officer.
In addition, Amosu will serve on key committees within Fox Chase, such as the Research Review Committee and Performance Improvement Committee, among others. He will also represent Fox Chase in the broader oncology arena, including on the guidelines committees of the National Comprehensive Cancer Network and the Pharmacy Directors Committee of the Alliance of Dedicated Cancer Centers.
Amosu has more than 25 years of pharmacy experience, with significant expertise in hematology/oncology pharmacy, clinical research, and pharmacy management. Most recently, he managed oncology clinical pharmacy services for Beebe Healthcare in Southern Delaware, where he led pharmacy operations for South Coastal Cancer Center and Tunnell Cancer Center.
Earlier in his career, he spent nearly 10 years at Medstar-Georgetown University Hospital – Vince Lombardi Comprehensive Cancer Center in Washington, D.C., in progressive roles in oncology and research pharmacy services. During this time, he also served as an adjunct clinical professor at Howard University School of Pharmacy.
As a consultant pharmacist throughout his career, Amosu has also designed oncology clinical pharmacy practice and chemotherapy services for privately owned outpatient cancer treatment centers, implementing best practice standards, reducing medication errors, and strengthening the oncology supply chain process.
Amosu earned both his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from Howard University. In addition, he holds a Master of Science in Health-System Pharmacy Administration from The Ohio State University.
He also holds a certificate in Data Analytics and Insights from the Wharton School at the University of Pennsylvania and a diploma in Pharmacy Leadership Training from the American Health Systems Pharmacy Leadership Academy. In addition, he is a member of the American Society of Health-System Pharmacists.
Amosu began his tenure at Fox Chase on August 7.